GlassScriptPhysician profile
Soren Carlsen
NPI 1063568657
$6,486.07
in general payments reported to CMS, 2019-2025
27 companies · $2,571 in 2025
The $2,571 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $589 · 2021: $520 · 2022: $679 · 2023: $805 · 2024: $1,097 · 2025: $2,571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,428 · Travel and Lodging: $1,582 · Education: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,428.46 |
| Travel and Lodging | $1,581.86 |
| Education | $463.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,612.43 | 2025 | Interstim |
| Astellas Pharma US INC | $1,153.52 | 2019-2025 | Xtandi, Padcev, Myrbetriq |
| Pfizer INC. | $596.76 | 2020-2025 | |
| Neotract INC. | $560.55 | 2019-2020 | |
| Abbvie INC. | $460.55 | 2019-2025 | Lupron Depot, Botox |
| Teleflex LLC | $411.00 | 2021-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $334.93 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $190.42 | 2020-2023 | Spaceoar System, Spaceoar Vue System - 10ml |
| Bluewind Medical | $141.07 | 2024 | |
| Rochester Medical Corporation | $132.32 | 2022 | |
| Myovant Sciences INC. | $121.99 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $117.54 | 2021-2024 | Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $112.47 | 2023-2024 | Bard Urinary Drainage Bag |
| Merck Sharp & Dohme LLC | $82.88 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Urogen Pharma, INC. | $77.85 | 2022-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $77.52 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.53 | 2023-2024 | |
| Axonics, INC. | $45.54 | 2021-2024 | Axonics |
| Sumitomo Pharma America, INC. | $44.81 | 2023-2025 | Orgovyx |
| Angiodynamics, INC. | $25.95 | 2025 | Nanoknife |
| Endo USA, INC. | $23.60 | 2025 | Xiaflex |
| Abc Home Medical Supply, INC. | $22.46 | 2025 | |
| Ferring Pharmaceuticals INC. | $21.27 | 2024 | Adstiladrin |
| Tolmar Pharmaceuticals, INC. | $17.49 | 2022 | |
| Allergan, INC. | $17.22 | 2021 | |
| Ambu INC. | $11.80 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soren Carlsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.